News Chart ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
8.1 ^USD	-3.57%		+2.27%	+61.35%

May. 09	ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 07	ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment	MT

d61ea4acced8b08beef7a59979.2Ydbv51nX2O1OEqswgqk1fkTkMTmn6DIR0KM1OSH8ak.vfcB0qkQLCCFfiTq9l-X5aBb2b6oqJKnNArkt7X_tJyB9BzRxAEYLYQIOQ~0bcaabe6860080a4c1398ff9750934e3